Literature DB >> 6460359

Lyt antigens on the T cells specific for minor histocompatibility antigens: suppression by a Lyt-1+2- regulator.

L M Pilarski, I F McKenzie.   

Abstract

The T cells involved in the cytotoxic response to minor histocompatibility antigens have been typed for Lyt-1 and Lyt-2 phenotype. BALB/c cytotoxic T cells specific for DBA/2 minor H antigens are H-2-restricted cells of the Lyt-1-2+ phenotype; they are derived for Lyt-1-2+ precursor cells that require collaborative interactions with Lyt-1+2- helper T cells. Suppressor T cells that are generated in vitro and whose function is radioresistant are able to inhibit the cytotoxic response to minor H. Unlike previously described inhibitory cell populations, these inhibitors are Lyt-1+2- cells. The experiments reported here were internally controlled to assess the specificity of the antisera. The results suggest that the cell that inhibits the response to minor H is quite different from the cell that inhibits the response to major H-2 antigens.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6460359     DOI: 10.1097/00007890-198111000-00004

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  4 in total

1.  Allospecific suppression without requirement for participation of Ly 2+ cells.

Authors:  V Holán; N A Mitchison
Journal:  Immunology       Date:  1984-03       Impact factor: 7.397

2.  I. Characterization of cytotoxic effector cells generated from regional lymph nodes after immunization in the footpad.

Authors:  A A Czitrom; N R Gascoigne
Journal:  Immunology       Date:  1983-09       Impact factor: 7.397

3.  Haplotype-specific suppression of cytotoxic T cell induction by antigen inappropriately presented on T cells.

Authors:  P J Fink; I L Weissman; M J Bevan
Journal:  J Exp Med       Date:  1983-01-01       Impact factor: 14.307

4.  Phenotype, specificity, and function of T cell subsets and T cell interactions involved in skin allograft rejection.

Authors:  A S Rosenberg; T Mizuochi; S O Sharrow; A Singer
Journal:  J Exp Med       Date:  1987-05-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.